BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
10 results:

  • 1. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
    Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
    World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting ccnd1].
    Lei K; Xie W; Sun T; Liu Y; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):712-717. PubMed ID: 35673915
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.
    Meagher MF; Mir MC; Autorino R; Minervini A; Kriegmair M; Maurer T; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; Musquera M; Roussel E; Pavan N; Antonelli A; Zhang S; Ghali F; Patel D; Javier-Desloges J; Bradshaw A; Rubio J; Guruli G; Tracey A; Campi R; Albersen M; Furlan M; McKay RR; Derweesh IH
    Clin Genitourin Cancer; 2022 Aug; 20(4):326-333. PubMed ID: 35585014
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
    Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
    Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunophenotype-Genotype Correlations in Clear Cell Sarcoma of kidney-An Evaluation of Diagnostic Ancillary Studies.
    Kenny C; Grehan D; Ulas M; Banga GB; Coulomb A; Vokuhl C; O'Sullivan MJ
    Pediatr Dev Pathol; 2020; 23(5):345-351. PubMed ID: 32364435
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
    Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
    Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Embolization of hypervascular bone metastases reduces intraoperative blood loss: a case-control study.
    Pazionis TJ; Papanastassiou ID; Maybody M; Healey JH
    Clin Orthop Relat Res; 2014 Oct; 472(10):3179-87. PubMed ID: 24964883
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].
    Waalkes S; Eggers H; Rustemeier J; Wegener G; Jentzmik F; Schrader M; Hofmann R; Kuczyk MA; Schrader AJ;
    Urologe A; 2011 Sep; 50(9):1118-24. PubMed ID: 21720831
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
    Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.